FDA 483 - Southwest Fertility Center - March 16, 2021

An FDA inspection of Southwest Fertility Center in Phoenix, AZ, identified a critical failure in donor screening protocols. The firm did not test donors of multiple oocyte and semen donations for West Nile Virus, a relevant communicable disease agent, before deeming them eligible. This lapse raises concerns regarding the safety and compliance of their reproductive tissue operations.